Swiss National Bank - THERAVANCE INC ownership

Quarter-by-quarter ownership
Swiss National Bank ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$1,127,000
+46.7%
106,9000.0%0.00%
+50.0%
Q3 2015$768,000
-54.3%
106,900
+14.9%
0.00%
-50.0%
Q2 2015$1,681,000
+11.8%
93,000
-2.7%
0.00%0.0%
Q1 2015$1,503,000
+12.7%
95,600
+1.4%
0.00%
-20.0%
Q4 2014$1,334,000
-13.5%
94,300
+4.4%
0.01%
-16.7%
Q3 2014$1,543,000
-43.4%
90,300
-1.3%
0.01%
-40.0%
Q2 2014$2,725,000
-3.7%
91,5000.0%0.01%
-9.1%
Q1 2014$2,831,000
+14.2%
91,500
+31.7%
0.01%
+10.0%
Q4 2013$2,478,000
-7.6%
69,500
+5.9%
0.01%
-9.1%
Q3 2013$2,682,000
+1.5%
65,600
-4.4%
0.01%
-8.3%
Q2 2013$2,643,00068,6000.01%
Other shareholders
THERAVANCE INC shareholders Q1 2016
NameSharesValueWeighting ↓
Baupost Group 20,395,056$607,365,0009.89%
Realm Partners LLC 301,521$8,979,0003.75%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,805,837$83,558,0002.52%
IRIDIAN ASSET MANAGEMENT LLC/CT 7,447,743$221,794,0002.27%
SECTORAL ASSET MANAGEMENT INC 1,743,188$51,912,0002.20%
Foundation Asset Management, LP 255,790$7,617,0002.19%
Proxima Capital Management, LLC 550,000$16,379,0001.93%
Roundview Capital LLC 140,645$4,188,0001.69%
BB BIOTECH AG 933,244$27,792,0001.32%
PERRY CAPITAL 1,517,208$45,182,0001.25%
View complete list of THERAVANCE INC shareholders